SkinHealth Systems Inc. Amortization of Intangible Assets
SkinHealth Systems Inc. (SKIN) reported Amortization of Intangible Assets of $7.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- SkinHealth Systems Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $3.51M, a 3.09% decline year-over-year.
- SkinHealth Systems Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $3.56M, a 11.89% increase year-over-year.
- SkinHealth Systems Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $3.48M, a 17.71% decline year-over-year.
- SkinHealth Systems Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $6.71M, a 32.67% increase year-over-year.
- SkinHealth Systems Inc. amortization of intangible assets for fiscal 2025 was $16.99M, a 13.05% decline from fiscal 2024.
- SkinHealth Systems Inc. amortization of intangible assets for fiscal 2024 was $19.54M, a 6.55% decline from fiscal 2023.
- SkinHealth Systems Inc. amortization of intangible assets for fiscal 2023 was $20.91M, a 40.77% increase from fiscal 2022.
- SkinHealth Systems Inc. amortization of intangible assets for fiscal 2022 was $14.85M, a 11.69% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.07M 10-Q · filed 2026-08-06 | $10.54M derived: sum of 3 quarters · filed 2026-08-06 | $17.25M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $3.56M 10-Q · filed 2026-05-07 | $7.03M derived: sum of 2 quarters · filed 2026-05-07 | $13.74M derived: sum of 3 quarters · filed 2026-05-07 | $17.37M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.19M derived: sum of 2 quarters · filed 2026-03-12 | $13.81M derived: sum of 3 quarters · filed 2026-08-06 | $16.99M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.33M derived: sum of 2 quarters · filed 2026-08-06 | $13.51M 10-Q · filed 2025-11-06 | $17.74M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.80M 10-Q · filed 2026-08-06 | $11.02M derived: sum of 3 quarters · filed 2026-08-06 | $16.08M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $3.18M 10-Q · filed 2026-05-07 | $7.40M derived: sum of 2 quarters · filed 2026-05-07 | $12.46M derived: sum of 3 quarters · filed 2026-05-07 | $17.73M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.28M derived: sum of 2 quarters · filed 2026-03-12 | $14.55M derived: sum of 3 quarters · filed 2026-03-12 | $19.54M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.33M derived: sum of 2 quarters · filed 2025-11-06 | $15.31M 10-Q · filed 2025-11-06 | $20.27M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-06-30 | $5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.26M 10-Q · filed 2025-08-07 | $15.21M derived: sum of 3 quarters · filed 2026-03-12 | $20.04M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-03-31 | $4.99M 10-Q · filed 2025-05-08 | $9.94M derived: sum of 2 quarters · filed 2026-03-12 | $14.77M derived: sum of 3 quarters · filed 2026-03-12 | $22.02M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2023-12-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.78M derived: sum of 2 quarters · filed 2026-03-12 | $17.03M derived: sum of 3 quarters · filed 2026-03-12 | $20.91M 10-K · filed 2026-03-12 | |||
| 2023-09-30 | $4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.08M derived: sum of 2 quarters · filed 2024-11-12 | $15.96M 10-Q · filed 2024-11-12 | $19.74M derived: sum of 4 quarters · filed 2025-03-12 | |||
| 2023-06-30 | $7.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $11.13M 10-Q · filed 2024-08-08 | $14.91M derived: sum of 3 quarters · filed 2025-03-12 | $18.61M derived: sum of 4 quarters · filed 2025-03-12 | |||
| 2023-03-31 | $3.87M 10-Q · filed 2024-05-09 | $7.66M derived: sum of 2 quarters · filed 2025-03-12 | $11.36M derived: sum of 3 quarters · filed 2025-03-12 | $15.15M derived: sum of 4 quarters · filed 2025-03-12 | |||
| 2022-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $7.48M derived: sum of 2 quarters · filed 2025-03-12 | $11.27M derived: sum of 3 quarters · filed 2025-03-12 | $14.85M 10-K · filed 2025-03-12 | |||
| 2022-09-30 | $3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $7.49M derived: sum of 2 quarters · filed 2023-11-14 | $11.06M 10-Q · filed 2023-11-14 | $9.60M 10-Q · filed 2022-11-09 | $15.98M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.37M 10-Q · filed 2023-08-09 | $6.47M 10-Q · filed 2022-08-09 | $12.28M derived: sum of 3 quarters · filed 2024-03-12 | $15.44M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-03-31 | $3.58M 10-Q · filed 2023-05-10 | $3.17M 10-Q · filed 2022-05-10 | $8.49M derived: sum of 2 quarters · filed 2024-03-12 | $11.65M derived: sum of 3 quarters · filed 2024-03-12 | $13.95M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2021-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $8.07M derived: sum of 2 quarters · filed 2024-03-12 | $10.38M derived: sum of 3 quarters · filed 2024-03-12 | $13.30M 10-K · filed 2024-03-12 | |||
| 2021-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.46M derived: sum of 2 quarters · filed 2022-11-09 | $8.38M 10-Q · filed 2022-11-09 | $11.57M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $5.23M 10-Q · filed 2022-08-09 | $8.41M derived: sum of 3 quarters · filed 2023-03-01 | $11.46M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $2.92M 10-Q · filed 2022-05-10 | $6.11M derived: sum of 2 quarters · filed 2023-03-01 | $9.15M derived: sum of 3 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.23M derived: sum of 2 quarters · filed 2023-03-01 | $11.85M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $3.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $8.66M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $5.62M 10-Q · filed 2021-08-13 | ||||||
| 2019-12-31 | $12.51M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |